Mihail Zilbermint, MD, MBA, FACE

Question Title

* 1. Name

Question Title

* 2. Email

Question Title

* 3. What is your professional designation?

Question Title

* 4. What is your specialty track?

Question Title

* 5. What setting do you practice in?

Question Title

* 6. How many patients do you see per month?

Question Title

* 7. Commercial Bias Definition: The Accreditation Council for Continuing Medical Education (ACCME) defines "commercial bias" as a personal judgment in favor of a specific proprietary business interest of a commercial interest. Based upon the ACCME's definition above, do you feel there was any commercial bias in this program?

Question Title

* 8. The faculty/speaker demonstrated experiential knowledge of the topic.

Question Title

* 9. As a result of my participation in this activity, I am better able to recognize the connection between managing T2D and how other serious complications, such as cardiovascular and chronic kidney disease, can also be avoided.

Question Title

* 10. As a result of my participation in this activity, I am better able to identify methods to intensify therapies to reach timely, sustained glycemic control targets (GLP-1 RA info).

Question Title

* 11. As a result of my participation in this activity, I am better able to apply shared decision-making strategies with sustained glycemic control targets and personalized treatment/management as critical goals in persons with diabetes to prevent long-term health implications. 

Question Title

* 12. Overall, I am satisfied with the program. 

Question Title

* 13. The content provided a fair and balanced coverage of the topic.

Question Title

* 14. The content of the activity was relevant to my practice.

Question Title

* 15. After participating in this activity, my knowledge of the subject matter has increased significantly.

Question Title

* 16. The activity increased my competence. 

Question Title

* 17. Do you plan to make changes in your practice as a result of attending this activity? If you do not, please share why.

Question Title

* 18. Please identify any changes in your practice that could occur as a result of your participation in the session. 

Question Title

* 19. Please identify any barriers or challenges that could prevent you from implementing these changes in your practice.

Question Title

* 20. What additional endocrinology issues do you face in your practice?

Question Title

* 21. What additional endocrinology content would be of interest to you?

T